Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Anti-Aging
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
NP Review: Clinical Implications of Atopic Dermatitis
In this video interview, Andrew Blauvelt, MD, MBA, dives into the current state of atopic dermatitis treatment from his talk presented at the Annual Society of Dermatology Nurse Practitioners Symposium, held April 22-23, in Nashville, Tennessee.
Andrew Blauvelt, MD, MBA, dermatologist and clinical researcher at the Oregon Medical Research Center, Portland, Oregon, highlights his key takeaways about the newest medications in the atopic dermatitis treatment world. He also touches on the different mechanisms of action and touches on the topic of JAK inhibitors.
Related Videos
Related Content
